Test can predict post-op radiotherapy outcomes in prostate cancer

A new study showed that a 24-gene signature can predict outcomes following postoperative radiotherapy in patients with prostate adenocarcinoma who underwent radical prostatectomy. The signature could help determine which patients should receive radiotherapy.
Cancer Network